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OBJECTIVE: To identify predictors of low cardiac output and mortality in decompensated heart failure.
INTRODUCTION: Introduction: Patients with decompensated heart failure have a high mortality rate, especially
those patients with low cardiac output. However, this clinical presentation is uncommon, and its management is
controversial.
METHODS: We studied a cohort of 452 patients hospitalized with decompensated heart failure with an ejection
fraction of ,0.45. Patients underwent clinical-hemodynamic assessment and Chagas disease immunoenzymatic
assay. Low cardiac output was defined according to L and C clinical-hemodynamic profiles. Multivariate analyses
assessed clinical outcomes. P,0.05 was considered significant.
RESULTS: The mean age was 60.1 years; 245 (54.2%) patients were .60 years, and 64.6% were men. Low cardiac
output was present in 281 (63%) patients on admission. Chagas disease was the cause of heart failure in 92 (20.4%)
patients who had higher B type natriuretic peptide levels (1,978.38 vs. 1,697.64 pg/mL; P= 0.015). Predictors of low
cardiac output were Chagas disease (RR: 3.655, P,0.001), lower ejection fraction (RR: 2.414, P,0.001), hyponatremia
(RR: 1.618, P =0.036), and renal dysfunction (RR: 1.916, P =0.007). Elderly patients were inversely associated with low
cardiac output (RR: 0.436, P = 0.001). Predictors of mortality were Chagas disease (RR: 2.286, P,0.001), ischemic
etiology (RR: 1.449, P = 0.035), and low cardiac output (RR: 1.419, P = 0.047).
CONCLUSIONS: In severe decompensated heart failure, predictors of low cardiac output are Chagas disease, lower
ejection fraction, hyponatremia, and renal dysfunction. Additionally, Chagas disease patients have higher B type
natriuretic peptide levels and a worse prognosis independent of lower ejection fraction.
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INTRODUCTION
Low cardiac output as the presenting feature of acute
decompensated heart failure is uncommon, ranging from
8.9%1 to 9.6%2 of hospitalized patients. Clinical-hemody-
namic assessment allows recognition of low cardiac output,
based on L and C profiles. In fact, Nohria et al3 demon-
strated that the L profile has a cardiac index average of
1.6 L/min/M2, and the C profile has an average of 1.9 L/
min/M2. Nevertheless, management of low cardiac output
has many difficulties and complexities. It is thought that
low cardiac output occurs in more advanced stages and in
more depressed systolic ventricular function. In addition,
factors such as the presence of hyponatremia and worsening
of renal function related to this situation could predict low
cardiac output. In our hospital, we have found that patients
with Chagas disease have more low cardiac output;
however, published heart failure registries have not
indicated this association.
Chagas disease is a major health problem in endemic
areas, mostly in South America, and its cardiac form causes
high mortality. Moreover, Chagas disease could appear in
nonendemic countries because of migration.4 Therefore, it is
important to describe the clinical presentation of heart
failure caused by Chagas disease.
Similarly, little data about decompensated heart failure in
the elderly are available, even in heart failure registries. Older
patients are more often referred to hospice after hospital
discharge; in addition, older women have a greater prob-
ability of a longer hospital stay.5 It has been established that
elderly patients have more diastolic than systolic dysfunction
in heart failure, including that caused by myocardial
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ischemia. However, clinical presentation and outcomes of
elderly patients with heart failure and depressed left
ventricular ejection fraction have not been studied.
Therefore, the purpose of this study was to identify
predictors of low cardiac output and mortality in decom-
pensated severe heart failure.
METHODS AND MATERIAL
We selected a cohort of patients hospitalized for acute
decompensation of chronic heart failure between 2005 and
2007, referred to a tertiary cardiology hospital. Inclusion
criteria were worsening of dyspnea at rest and ejection
fraction ,0.45. Exclusion criteria were aortic stenosis, acute
coronary syndromes, stroke, and coronary bypass or
percutaneous coronary angioplasty in the previous 2
months.
We divided the patients according to age $60 years and
,60 years, and we analyzed variables related to heart
failure. We also divided the patients according to the
presence or absence of Chagas disease, defined by serologic
testing with enzyme immunoassay.
Low cardiac output was defined based on C (with
congestion signs) and L (without congestion signs) profiles
in clinical hemodynamic assessment.6 Compromised perfu-
sion was assessed by the presence of a narrow pulse
pressure, symptomatic hypotension, cool extremities,
impaired mental function, or a combination of these.
Laboratory analyses were done at admission and follow-
up, according to clinical criteria. The ‘‘Modification of Diet
in Renal Disease’’ (MDRD) method calculated creatinine
clearance,7 through the following formula: glomerular fil-
tration rate = 1866 [serum creatinine] -1,1546 [age] -0.2036
[0.742 if patient is female]6 [1,212 if patient is black]. After
that, we defined 3 groups according to renal function: G1:
baseline creatinine clearance .60 mL/min; G2: baseline
creatinine clearance ,60 mL/min, and increase .10 mL/
min during hospitalization (with recovery); and G3: baseline
creatinine clearance ,60 mL/min, and sustained renal
dysfunction during hospitalization (without recovery).
Hyponatremia was defined as serum Na ,137 mEq/L.
Plasma concentrations of B type natriuretic peptide (BNP)
were analyzed by using ADVIA Centaur BNP-analysis
(Bayer, Leverkusen, Germany), and expressed in pg/mL.
Heart failure management routine
After definition of the clinical-hemodynamic profile for
each patient, those with low output signs (‘‘cold’’, L and C
profiles) were treated with intravenous inotropic support:
dobutamine, milrinone, or levosimendan. Patients with
symptoms and signs of pulmonary or systemic congestion
received a diuretic, intravenous furosemide with or without
hydrochlorothiazide. Oral vasodilators, such as angiotensin-
converting enzyme (ACE) inhibitors, angiotensin-receptor
blocker, and hydralazine, were optimized during hospitali-
zation, to reach the target daily dosage, or in association
between these vasodilators. Beta-blockers currently being
takenwere continued, but their dosages were reduced by half
at admission. Patients were followed up after discharge
through telephone contact or computerizedmedical consults.
Statistical analysis
Continuous variables are expressed as mean and stan-
dard deviation, and were compared by using the Student t
test. BNP levels were transformed by logarithmic correction
to compare groups. Categorical variables are expressed by
number and proportion and compared by using the chi-
square test or Fisher’s test. We considered P-value ,0.05 (2-
tailed) as significant.
Predictors of low cardiac output were defined by logistic
regression,8 and they are expressed by relative risk and 95%
confidence interval. Predictors of all-cause mortality were
defined by Cox regression, and they are expressed by
relative risk and 95% confidence interval. Survival curves
were developed by using the Kaplan-Meier method and
compared by using log-rank test.9
Informed consent was obtained at admission, and the
study protocol conformed to the ethical guidelines of the
1975 Declaration of Helsinki.
RESULTS
We studied 452 patients between February of 2005 and
April 2007. As show in Table 1, the majority of patients were
men, with a mean age 60.1 years old. According to the cause
of heart failure, 151 (33.9%) patients had ischemic myocar-
diopathy, 107 (24.0%) patients had hypertensive myocardio-
pathy, and 92 (20.6%) patients had Chagas disease.
Moreover, Chagas disease patients were younger (53.0 ¡
12.7 vs. 62.0 ¡ 14.7 years, P,0.001), and they had lower
ejection fraction (22.9 ¡ 8.0 vs. 26.7 ¡ 8.4%, P,0.001). In
addition, Chagas disease (n = 45) patients had higher BNP
levels (1,978.38 vs. 1,697.64 pg/mL; P= 0.015).
On the other hand, patients older than 60 years old had
higher ejection fractions, and they (n= 111) had similar BNP
levels (1,823.53 vs. 1,683.53 pg/mL, P= 0.375).
Predictors of low cardiac output
Low cardiac output was present in 251 (63%) who
required intravenous inotropic drugs, which were dobuta-
mine in 249 patients, levosimendan in 22 patients, and
milrinone in 21 patients, and included simultaneous
infusion. Variables included in the logistic regression
analysis were Chagas disease, ischemic cardiomyopathy,
age .60 years, admission creatinine clearance ,60 mL/
min/M2, ejection fraction ,0.25, serum Na ,137 mEq/L,
and Caucasian ethnicity. Moreover, predictors of low
cardiac output, as shown in Figure 1, were Chagas disease,
lower ejection fraction, and renal dysfunction. Conversely,
old age was inversely associated with inotropic support.
Predictors of all-cause mortality
At a mean follow-up of 17.2 ¡ 0.66 months, 173 (38.8%)
patients had died. Variables included in Cox regression
analysis were Chagas disease, ischemic cardiomyopathy,
Table 1 - Baseline characteristics.
Men (%) 292 (64.6)
Age (years) 60.1 ¡ 14.8
Age . 60 years old (%) 245 (54.9)
LVEF 0.26 ¡ 0.08
Intravenous inotropic drug 281 (63.0)
Beta-blocker 312 (69.9)
ACE inhibitor 277 (62.1)
Creatinine clearance (ml/min*1.73 m2) 57.4 ¡ 26.9
Sodium (mEq/L) 137.4 ¡ 4.4
LVEF: Left ventricular ejection fraction, ACE: angiotensin-converting
enzyme
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low cardiac output, age .60 years, admission creatinine
clearance ,60 mL/min/M2, ejection fraction ,0.25, serum
Na ,137 mEq/L, and ACE inhibitor, beta-blocker, hydra-
lazine, and spironolactone. Multivariate analysis identified
Chagas disease, ischemic myocardiopathy, low cardiac
output, and renal dysfunction (creatinine clearance
,60 mL/min) as predictors of mortality, and ACE inhibitor
and beta-blocker as predictors of lower mortality (Figure 2).
Survival curves showed a worse prognosis for Chagas
disease (Figure 3).
Renal function during hospitalization
Two or more measurements of creatinine clearance were
available in 384 patients. Creatinine clearance was ,60 mL/
min in 223 patients (58.1%) at admission, and 98 (44%)
patients had an increase of 10 mL/min during hospitaliza-
tion. The remaining patients had first creatinine clearance
.60 mL/min, and they kept it above this value during
hospitalization. The group with recovery of renal function
had a trend of lower mortality than patients with sustained
renal dysfunction (Figure 4).
Figure 1 - Predictors of low cardiac output in decompesated heart failure.
Figure 2 - Predictors of all-cause mortality.
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Figure 3 - Survival curves according to Chagas disease or not.
Figure 4 - Survival curves according to renal function evolution. CrCl = creatinine clearance.
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DISCUSSION
To our knowledge, this is the first study to demonstrate
an association between Chagas disease heart failure and low
cardiac output during decompensation.
The main finding of the present study is that Chagas
disease is a predictor of low cardiac output and mortality in
decompensated severe heart failure. Additionally, BNP
levels were higher in Chagas disease patients. We also
observed an association between older age and lower
incidence of low cardiac output. Older patients had higher
ejection fractions and similar BNP levels compared with
younger patients.
The presence of low cardiac output in the setting of
decompensated heart failure represents a very high-risk
situation. We emphasize that this hemodynamic profile has
important differences from large-scale clinical registries
such as ADHERE.
In our sample, low cardiac output was a more frequent
profile of heart failure decompensation. This finding is
compatible with findings in patients referred to tertiary
cardiology centers for treatment of advanced heart failure.
Although, low cardiac output is uncommon in the general
setting, it requires a type of management with complicated
and controversial decisions, such as the choice between
vasodilators and inotropes.
In this context, clinical assessment of the hemodynamic
profile helps us to identify low cardiac output, and
consequently adequate therapy can be adopted. L and C
profiles show a cardiac index lower (1.6 ¡ 0.5 and 1.9¡
0.7 L/min/m2, respectively) than normal limits6. In addi-
tion, predictors of low cardiac output may be helpful.
Chronic Trypanosoma cruzi infection (Chagas disease)
frequently causes heart failure in persons living in rural
areas of South America; however, it is becoming a problem
in nonendemic areas or countries, as has happened in our
city, mostly due to the migration of populations.
Differences in hystopathologic characteristics,10 malig-
nant cardiac arrhythmia and higher mortality have been
described in Chagas cardiomyopathy.11 In principle, a
worse prognosis was attributed to more intense myocardial
damage and left ventricular dysfunction. Most trials that
have studied Chagas disease have been done in patients
with stable chronic heart failure; however, the clinical
presentation of decompensated heart failure has not been
described.
Chagas cardiomyopathy causes more severe systolic
dysfunction, although, in our sample it predicted low
cardiac output independently from lower left ventricular
ejection fraction. Consequently, it is probable that peripheral
vascular resistance increased. Negra˜o et al12 found a similar
muscle sympathetic nerve activity in Chagas cardiomyo-
pathy in relation to other causes of heart failure. In addition,
forearm vascular conductance was reduced, as was non-
Chagas heart failure. Moreover, lower levels of catechola-
mine in Chagas heart failure have been demonstrated,
differently from non-Chagas disease patients13. It is possible
that problems of adaptive mechanisms, such as the lack of
sympathetic and renin-angiotensin-system activation, could
contribute to low cardiac output like decompensated heart
failure presentation. In addition, our Chagas disease
patients had higher levels of BNP than non-Chagas heart
failure patients had, which is compatible with more severe
left ventricular dysfunction. Other authors have described
this finding;14 however, baseline BNP of our sample was
very high in both Chagas and non-Chagas heart failure.
Others predictors of low cardiac output and
mortality
Decompensated heart failure in elderly patients has been
studied very little as yet. In our cohort, we found a lower
incidence of low cardiac output and similar BNP levels than
those in younger patients. These findings are compatible
with findings with more frequent ischemic causes and
reduced compliance of the great arteries in elderly people.
Decompensated heart failure in the elderly is character-
ized by more diastolic dysfunction, more worsening renal
function,15 worse cognitive function,16 and a worse prog-
nosis. Our results are compatible with those of the ADHERE
study, which found younger age and ejection fraction in
patients who required inotropic therapy.2
We found a trend of a better prognosis among patients
who recovered from renal dysfunction. The pathophysiol-
ogy of cardio-renal syndrome involves interaction between
neurohormonal changes, hemodynamic condition, and drug
therapy. In addition, the presence of renal dysfunction in
heart failure has been described as a predictor of mortality
in compensated as well as decompensated phases.
However, recovery of renal function has not been evaluated
in the setting of decompensated heart failure.
It is possible that recovery of renal function just reflects a
better cardiac situation during decompensation. Never-
theless, renal recovery indicates a better prognosis through
widely available MDRD creatinine clearance. It is likely that
hemodynamic condition, ie, low cardiac output, is the most
important factor of worsening renal function during the
decompensation of heart failure.
Because the exponential relationship between glomerular
filtration rate and serum creatinine, small changes in serum
creatinine result in greater reductions in its clearance at low
Table 2 - Univariate analysis according to etiology.
Variables Chagas disease (N=92) Non-Chagas disease (N= 360) P-value
Age (y) 53.0 ¡ 12.7 62.0 ¡ 14.7 , 0.001
Men (%) 55 (59.8%) 237 (65.8%) 0.279
ACE inhibitor (%) 59 (64%) 218 (60.5%) 0.530
Beta blocker (%) 62 (67.4%) 250 (69.4%) 0.704
Low cardiac output (%) 79 (85.9%) 201 (55.8%) ,0.001
Ejection fraction (%) 22.9 ¡ 8.0 26.7 ¡ 8.4 , 0.001
Creatinine clearance (mL/min*M2) 61.3 ¡ 23.0 56.4 ¡ 27.7 0.119
Serum Na (mEq/L) 135.8 ¡ 4.6 137.8 ¡ 4.3 , 0.001
BNP (pg/mL) (available) 1,978.38 ¡ 1,314.02 (N=45) 1,697.64 ¡ 1,376.06 (N=161) 0.015
ACE: angiotensin-converting enzyme, BNP : B type Natriuretic peptide
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initial serum creatinine compared with higher serum
creatinine levels.17 Despite of this limitation the majority
of recently published studies about renal dysfunction in
heart failure have used calculated glomerular filtration rate
based on MDRD equation.18,19 Additionally, MDRD equa-
tion has been validated in heart failure patients.20
Study limitations
Our study assessed the clinical presentation of patients
with decompensated heart failure; however, we did not
study the neurohormonal condition of these patients. We
defined low cardiac output through clinical hemodynamic
bedside assessment, but actually we did not measure
cardiac index or ventricular filling pressures.
CONCLUSIONS
In severe decompensated heart failure, Chagas disease,
lower ejection fraction, hyponatremia, and renal dysfunc-
tion predicted low cardiac output. Additionally, Chagas
disease patients had greater BNP levels and a worse
prognosis, independently from lower ejection fraction.
REFERENCES
1. Gheorghiade M, Abraham WT, Albert NM, Gattis Stough W, Greenberg
BH, O’Connor CM, et al. OPTIMIZE-HF Investigators and Coordinators.
Relationship between admission serum sodium concentration and
clinical outcomes in patients hospitalized for heart failure: an analysis
from the OPTIMIZE-HF registry. Eur Heart J. 2007;28:980-8, doi: 10.
1093/eurheartj/ehl542.
2. Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL,
LeJemtel TH, et al. In-hospital mortality in patients with acute
decompensated heart failure requiring intravenous vasoactive medica-
tions: an analysis from the Acute Decompensated Heart Failure National
Registry (ADHERE). J Am Coll Cardiol. 2005;46:57-64, doi: 10.1016/j.jacc.
2005.03.051.
3. Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, et al.
Clinical assessment identifies hemodynamic profiles that predict out-
comes in patients admitted with heart failure. J Am Coll Cardiol.
2003;41:1797-804, doi: 10.1016/S0735-1097(03)00309-7.
4. Bern C, Montgomery SP, Herwaldt BL, Rassi Jr. A, Marin-Neto JA,
Dantas RO, et al. Evaluation and treatment of Chagas Disease in the
United States. A systematic review. JAMA. 2007;298:2171-81, doi: 10.
1001/jama.298.18.2171.
5. Hauptman PJ, Goodlin SJ, Lopatin M, Costanzo MR, Fonarow GC, Yancy
C. Characteristics of patients hospitalized with acute decompensated
heart failure who are referred for hospice care. Arch Intern Med.
2007;167:1990-7, doi: 10.1001/archinte.167.18.1990.
6. Nohria A, Lewis E, Stevenson LW. Medical management of advanced
heart failure. JAMA. 2002;287:628-40, doi: 10.1001/jama.287.5.628
7. O’Meara E, Chong KS, Gardner RS, Jardine AG, Neilly JB, McDonagh
TA. The Modification of Diet in Renal Disease (MDRD) equations
provide valid estimations of glomerular filtration rates in patients with
advanced heart failure. Eur J Heart Fail. 2006;8:63-7, doi: 10.1016/j.
ejheart.2005.04.013.
8. Hosmer DW, Lemeshow S. Applied logistic regression. New York:
Wiley; 1989. p. 106-18.
9. Lee ET. Statistical methods for survival data analysis. 1st ed. Belmont
(CA): Lifetime Learning Publications; 1980.
10. Tostes S Jr, Bertulucci Rocha-Rodrigues D, de Araujo Pereira G, Rodrigues
V Jr. Myocardiocyte apoptosis in heart failure in chronic Chagas’ disease.
Int J Cardiol. 2005;18:233-7, doi: 10.1016/j.ijcard.2004.01.026.
11. Rassi A Jr, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, et al.
Development and validation of a risk score for predicting death in
Chagas’ heart disease. N Engl J Med. 2006;355:799-808, doi: 10.1056/
NEJMoa053241.
12. Negra˜o CE, Santos AC, Rondon MU, Franco FG, Ianni B, Rochitte CE,
et al. Muscle sympathetic nerve activity in patients with Chagas’ disease.
Int J Cardiol. 2009;137:252-9, doi: 10.1016/j.ijcard.2008.06.093.
13. Guimaraes GV, D’ Avila V, Bocchi EA, Carvalho VO. Norepinephrine
remains increased in the six-minute walking test after heart transplanta-
tion. Clinics. 2010;65:587-91.
14. Vilas-Boas F, Feitosa GS, Soares MB, Pinho-Filho JA, Nascimento T,
Barojas MM, et al. Invasive and noninvasive correlations of B-type
natriuretic Peptide in patients with heart failure due to chagas cardiom-
yopathy. Congest Heart Fail. 2008;14:121-6, doi: 10.1111/j.1751-7133.
2008.08166.x.
15. Krumholz HM, Chen YT, Vaccarino V, Wang Y, Radford MJ, Bradford
WD, et al. Correlates and impact on outcomes of worsening renal
function in patients .65 years of age with heart failure. Am J Cardiol.
2000;85:1110-3, doi: 10.1016/S0002-9149(00)00705-0.
16. Ochiai ME, Franco LL, Gebara OC, Nussbacher A, Serro-Azul JB, Pierri
H, et al. [Correlation between evolution of the cognitive function and
mortality after hospital discharge in elderly patients with advanced heart
failure]. Arq Bras Cardiol. 2004;82:251-4, doi: 10.1590/S0066-
782X2004000300005.
17. Tang WH, Mullens W. Cardiorenal syndrome in decompensated heart
failure. Heart. 2010;96:255-60, doi: 10.1136/hrt.2009.166256.
18. Aronson D, Burger AJ. The relationship between transient and persistent
worsening renal function and mortality in patients with acute decom-
pensated heart failure. J Card Fail. 2010;16:541-7, doi: 10.1016/j.cardfail.
2010.02.001.
19. Amsalem Y, Garty M, Schwartz R, Sandach A, Behar S, Caspi A, et al.
Prevalence and significance of unrecognized renal insufficiency in
patients with heart failure. Eur Heart J. 2008;29:1029-36, doi: 10.1093/
eurheartj/ehn102.
20. O’Meara E, Chong KS, Gardner RS, Jardine AG, Neilly JB, McDonagh
TA. The Modification of Diet in Renal Disease (MDRD) equations
provide valid estimations of glomerular filtration rates in patients with
advanced heart failure. Eur J Heart Fail. 2006;8:63-7, doi: 10.1016/j.
ejheart.2005.04.013.
Low cardiac output in decompensated heart failure
Ochiai ME et al.
CLINICS 2011;66(2):239-244
244
